Polygenic Risk Scores: Revolutionizing Our Understanding of Cardiac Health

What if a single score could predict your risk for diseases like diabetes, heart disease, and even cancer? Welcome to the world of polygenic risk scores (PRS), the cutting-edge frontier of personalized medicine.

What is a PRS?

Think of PRS as a personalized risk assessment based on DNA. It analyzes thousands of tiny genetic variations, each with a small influence, to create a score indicating susceptibility to a specific disease, like those affecting cardiometabolic health.

Cardiometabolic Health: A Personalized Approach

Conditions like heart disease, diabetes, and high blood pressure (cardiometabolic diseases) are a complex dance between genes and environment. PRS can be a game-changer:

  • Personalized Risk Assessment: By pinpointing individuals with a higher genetic risk, PRS allows for earlier intervention and tailored prevention strategies.
  • Tailored Interventions: Individuals can receive customized advice on lifestyle changes and medical interventions to mitigate genetic risk.  
  • Enhanced Screening: Integrating PRS into screening programs improves accuracy of identifying high-risk individuals, ensuring timely preventative measures.
  • Empowering Patients: Knowledge of genetic risk empowers individuals to take proactive steps towards better health, fostering motivation for adherence to preventive measures.

Gene by Gene’s Role in PRS for a healthier tomorrow 

We're proud to be at the forefront of this exciting field. By providing PRS genomic laboratory testing services to leading global providers, we're helping to advance personalized medicine on a massive scale.  These providers don't just rely on genetic data alone; they incorporate comprehensive medical histories and clinical factors into their PRS algorithms. This holistic approach ensures that the risk scores are more accurate and reflective of an individual's overall health profile, leading to better-informed healthcare decisions and personalized treatment plans.

The future of cardiometabolic health is personalized, and PRS is paving the way for a healthier tomorrow.

Last updated Jul 31, 2024

Gene By Gene is a world leader in genetic testing services with over 20 years of experience. Our laboratory holds accreditation from multiple agencies, including CAP, CLIA, California Department of Public Health, and AABB. With a cutting-edge laboratory and highly trained team of experts, we are committed to excellence in the field of genetic analysis.

Enquire about Gene by Gene Services

Discover how Gene by Gene can help you and your organisation leverage advanced robotic technology & unlock a personalized end-to-end workflow.

Thank you!

Your submission has been received. Our laboratory will be in touch soon to follow up your enquiry.
An error occurred while submitting the form. Please try again. If the issue persists, please contact our support team.

More Gene by Gene News

Cholesterol Awareness Month Spotlight: Exome Sequencing - A Breakthrough in the Fight Against Familial Hypercholesterolemia

Cholesterol Awareness Month Spotlight: Exome Sequencing - A Breakthrough in the Fight Against Familial Hypercholesterolemia

Understanding Familial Hypercholesterolemia (FH)

Read Article >
We have expanded our NGS Capabilities with New Tech Investment

We have expanded our NGS Capabilities with New Tech Investment

As a leading CLIA/CAP-certified laboratory, we are proud to announce a major investment in next-generation sequencing (NGS) technology, reaffirming our commitment to further expanding advancements in our, already established, NGS Capability.

Read Article >
World Lung Cancer Day and the role of Whole Exome Sequencing (“WES”) in Inherited Risk

World Lung Cancer Day and the role of Whole Exome Sequencing (“WES”) in Inherited Risk

World Lung Cancer Day, observed annually on August 1st, is a crucial platform to raise awareness about lung cancer, its prevention, early detection, and treatment.

Read Article >
Great news for California residents, with personalized medicine more accessible

Great news for California residents, with personalized medicine more accessible

California residents with Medi-Cal, the state's Medicaid program, can now benefit from personalized medicine thanks to a new law. As of July 1, 2024, pharmacogenomic (PGx) testing is a covered benefit, joining Medicare in offering this valuable tool for optimizing medication treatment.

Read Article >
Breast Cancer: A New Era of Personalized Care with Precision Medicine and DNA Testing

Breast Cancer: A New Era of Personalized Care with Precision Medicine and DNA Testing

Breast cancer casts a long shadow, holding the unfortunate distinction of being the most common cancer affecting women globally.

Read Article >